Enter Symbol or Keyword(s) Timeframe to Milestone Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Clinical and Corporate Update 7:16 AM EDT 5/11/2023 - Comtex MONTREAL and CHARLOTTE, N.C., May 11, 2023 (Canada NewsWire via COMTEX News Network) -- - NDA submission for etripamil in patients with PSVT currently on track for 3Q23 - Company to host virtual KOL event focused on etripamil for the potential treatment of AFib-RVR on Monday, May 22, 2023 - Topline data from...
